BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 27
• 28

• Business

  Gilead Sciences, Inc. Bags Blood Disorder Drug With $510 Million YM BioSciences Buy

  December 12, 2012

   · 

  10 min read
• Biotech Beach

  Independent Study Validates Bio-Rad Laboratories, Inc.'s Droplet Digital™ PCR Technology for Analyzing Archival Cancer Samples

  December 12, 2012

   · 

  4 min read
• FDA

  Sucampo Pharmaceuticals, Inc. Gets Nod for Glaucoma Drug From FDA

  December 12, 2012

   · 

  6 min read
• Drug Development

  FibroGen, Inc. and Astellas Pharma Inc. Announce Initiation of Phase 3 Trial of FG-4592/ASP1517 for Treatment of Anemia of Chronic Kidney Disease

  December 12, 2012

   · 

  1 min read
• Policy

  Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin/Metformin Fixed-Dose Combination Therapy to Treat Patients with Type 2 Diabetes

  December 12, 2012

   · 

  5 min read
• Job Trends

  Roche to Invest $257 Million Into German Site; 50 New Jobs

  December 12, 2012

   · 

  1 min read
• BioMidwest

  CeraPedics, Inc. Secures $19 Million Series C Financing

  December 12, 2012

   · 

  4 min read
• Business

  The Medicines Company Licenses Bristol-Myers Squibb Company’ Bleeding Control Device for $105 Million

  December 12, 2012

   · 

  7 min read
• Deals

  The Medicines Company to Acquire Incline Therapeutics for About $185 Million

  December 12, 2012

   · 

  7 min read
• Drug Development

  Pharmacyclics, Inc. Announces Updated Results for BTK Inhibitor Ibrutinib (PCI-32765) at American Society of Hematology (ASH) Annual Meeting

  December 12, 2012

   · 

  16 min read